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Abstract Pim-1, an oncogene product of serine/threonine
kinase, has been found to play roles in apoptosis induction/
suppression, cell-cycle progression and transcriptional regulation
by phosphorylating the target proteins involved in these
processes. The target proteins phosphorylated by Pim-1,
including p100, Cdc25A, PAP-1 and heterochromatin protein
1, have been identified. The precise functions of Pim-1, however,
are still poorly understood. In this study, we identified tumor
necrosis factor receptor-associated factor 4-associated factor
2/sorting nexin 6 (TFAF2/SNX6) as a Pim-1-binding protein,
and we found that TFAF2/SNX6 was phosphorylated and
translocated from the cytoplasm to nucleus by Pim-1. This
translocation of the protein was not affected by Pim-1-dependent
phosphorylation. Since sorting nexins, including TFAF2/SNX6,
have been reported to be located in the cytoplasm or membrane
by association with several receptors of tyrosine- or serine/
threonine-kinase, this is the first report of TFAF2/SNX6 being
located in the nucleus after binding to Pim-1. ß 2001 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Pim-1 is a protooncogene product that possesses a serine/
threonine protein kinase activity and has been found to be
cooperate with c-Myc, another protooncogene product, in
lymphomagenesis [1^4]. Recently, Pim-2 and Pim-3/Kid1, oth-
er Pim-family proteins, have been identi¢ed [5^8], and the
functions of these proteins appear to complement each other
in mice in which the gene for one of the Pim-family proteins
was disrupted, thereby giving no severe defect [9]. Pim-1 is
located both in the cytoplasm and nucleus, but the distinct
roles of Pim-1 in these two locations have not been elucidated.
To analyze the functions of Pim-1, several binding- and phos-
phorylation-target proteins of Pim-1 have been identi¢ed.
These proteins include p100, which is an activator of c-Myb
transcription factor [10] ; cdc25A of protein phosphatase,
which activates Cdk2, leading to progression of the cell cycle
[11] ; HP-1, which is a heterochromatin-binding protein and
works in gene silencing [12] ; and PAP-1, which is a novel
protein functioning in transcription repression and splicing
regulation [13]. All of these proteins are located in the nu-
cleus, where Pim-1 is colocalized with these proteins. Pim-1
has been know to be involved in the cytokine signaling path-
way [14^17]. In interleukin 6 (IL-6)-drive signaling in lympho-
cyte-lineage cells, STAT3 targets both c-myc and pim-1 genes
and functions in cell-cycle progression and cell survival, anti-
apoptotic functions [18,19]. In ¢broblasts, on the other hand,
a proapoptotic function of Pim-1 dependent on c-myc has
been reported [11,20,21]. Despite these recent ¢ndings regard-
ing Pim-1, the precise functions of Pim-1 are still poorly
understood.
In order to try to determine the functions of Pim-1, we have
carried out a yeast two-hybrid screening to identify Pim-1-
binding proteins. In this study, in addition to PAP-1 and
HP-1, which we previously identi¢ed [12,13], we identi¢ed
TFAF2/SNX6 (tumor necrosis factor receptor-associated fac-
tor 4 (TRAF4)-associated factor 2/sorting nexin 6) as a Pim-1-
binding protein. The cDNAs of TFAF2 and SNX6 were in-
dependently cloned by us and others as cDNAs encoding
TRAF4-binding protein and Smad1, epidermal growth factor
(EGF)- or transforming growth factor (TGF)-L receptors
[22,23], respectively. In these combinations, TFAF2/SNX6 is
located in the cytoplasm targeting the Golgi network [23]. In
this study, we found that TFAF2/SNX6 is translocated from
the cytoplasm to nucleus by phosphorylation function-inde-
pendent Pim-1.
2. Materials and methods
2.1. Cells
Human 293T and HeLa cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium with 10% calf serum.
2.2. Plasmids
pGLex-Pim-1v2, pcDNA3-FLAG-Pim-1 and pcDNA3-Pim-1-dele-
tion mutants were described previously [12]. pcDNA3-hemagglutinin-
tagged (HA)-TFAF2 and pcDNA3-FLAG-TFAF2: TFAF2 cDNA
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was inserted into EcoRI^Xho1 sites of pcDNA-HA and pcDNA3-
FLAG, respectively [12]. pACT-TFAF2 and pACT-TFAF2-deletion
mutants: cDNAs of TFAF2 starting from the ¢rst ATG and of
TFAF2-deletion mutants synthesized by PCR were inserted into
EcoRI^XhoI sites of pACT2.
2.3. In vivo-binding assay
1 Wg of pCMV-FLAG-Pim-1 together with 1 Wg of pCMV-HA-
TFAF2 was transfected to human 293T cells 60% con£uent in a
10 cm dish using Lipofect Amine plus (Gibco BRL). Fourty-eight
hours after transfection, the whole cell extract was prepared by the
published procedure [24]. Approximately 500 Wg of the 293T cell
proteins was ¢rst immunoprecipitated with a mouse anti-FLAG anti-
body (M2, Sigma) in a bu¡er containing 50 mM NaCl, 5 mM EDTA,
50 mM Tris (pH 7.5), 1 mg/ml bovine serum albumin, 150 Wg/ml
phenylmethylsulfonyl £uoride and 0.25% NP-40. After washing with
the same bu¡er except for 0.05% instead of 0.25% NP-40, the precip-
itates were separated in a 12% polyacrylamide gel containing SDS,
blotted onto a nitrocellulose ¢lter, and reacted with a mouse anti-HA
antibody 12CA5 [25,26] or with the mouse anti-FLAG antibody.
2.4. Kinase assay
Glutathione S-transferase (GST) or GST^TFAF2 was expressed in
Escherichia coli and puri¢ed as described above. In vitro-kinase reac-
tions were carried out at 22‡C for 20 min in a mixture containing 250
ng of either GST or GST^TFAF2, 2 Wg of GST-free Pim-1, and 10
WCi (3000 Ci/mmol) of [Q-32P]ATP in 200 Wl of a kinase bu¡er (25 mM
HEPES^KOH (pH 7.5), 30 mM NaCl, 10 mM MgCl2, and 0.5 mM
dithiothreitol). The reaction mixture was boiled in Laemmli bu¡er,
and phosphorylated proteins were separated in a 12% polyacrylamide
gel containing SDS, followed by autoradiography.
2.5. Indirect immuno£uorescence
Human HeLa cells were cotransfected with pcDNA3-FLAG-Pim-1
and pcDNA3-HA-TFAF2 by the calcium phosphate precipitation
technique [27]. Forty-eight hours after transfection, the cells were
¢xed with a solution containing 4% paraformaldehyde and reacted
with a mouse anti-FLAG monoclonal antibody (M2, Sigma) or
anti-HA polyclonal antibody (Y-11, Santa Cruz). The cells were
then reacted with an FITC-conjugated anti-mouse IgG or rhoda-
mine-conjugated anti-rabbit IgG and observed under a confocal laser
£uorescent microscope.
3. Results and discussion
3.1. Identi¢cation of TFAF2/SNX6 as a Pim-1-binding protein
and determination of the Pim-1-binding region
To screen cDNAs encoding Pim-1-associating proteins,
two-hybrid screening was carried out with Pim-1v2, an N-ter-
minal fragment containing amino acids 1^93, as bait using a
human cDNA library as described previously [12]. In addi-
tion to heterochromatin protein 1Q (HP-1Q), a partial cDNA
encoding a region spanning amino acids 1^179 of TFAF2/
SNX6 was obtained. We and others have already cloned
cDNAs of TFAF2 or SNX6 by screening of the cDNA of a
protein binding to TRAF4 (data not shown, accession num-
ber of TFAF2 cDNA sequence is U83194) or a Smad1-bind-
ing protein [22]. TFAF2/SNX6 was comprised of at least two
domains, a phox-homology (PX) domain and a coiled coil
region, which were thought to be important domains for its
function [22,23]. To determine the Pim-1-binding region of
TFAF2/SNX6, various deletion constructs fused to the
GAL4-activation domain were used for a two-hybrid assay
with Pim-1v2 as bait and the results of ¢lter and liquid assays
were shown (Fig. 1). Except for TFAF2-N, containing amino
Fig. 1. Identi¢cation of the Pim-1-binding region in TFAF2. Saccharomyces cerevisiae L40 cells were cotransformed with pGLex-Pim-1v2 and
a series of deletion constructs fused with the GAL4-activation domain, and the L-galactosidase activity of each colony was tested. After incuba-
tion in liquid medium or on ¢lters, the L-galactosidase activity was assayed, and relative intensities of L-galactosidase activity are shown on the
left. PX indicates the domain in TFAF2.
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acids 1^179, no clones bound to Pim-1, indicating that Pim-1
binds to the N-terminal-half region of TFAF2, including the
PX domain (Fig. 1). To examine a complex formation of
TFAF2 with Pim-1 in vivo, expression vectors for FLAG-
tagged wild-type (wt) Pim-1 or kinase-negative Pim-1, in
which lysine at amino acid 67 had been changed to methio-
nine (KM), was cotransfected together with HA-TFAF2 to
human 293T cells. Forty-eight hours after transfection, the
cell extract was prepared and the proteins in the extract
were ¢rst immunoprecipitated with an anti-FLAG antibody
or non-speci¢c IgG. The precipitates were divided to two ali-
quots, and each of the precipitates was immunoblotted against
either the anti-FLAG antibody or an anti-HA antibody (Fig.
2A). The anti-HA antibody was ¢rst con¢rmed not to react
FLAG-Pim-1 in cell extract by Western blotting (data not
shown). The anti-FLAG antibody precipitated FLAG-Pim-
1-wt and FLAG-Pim-1-KM (Fig. 2A, F-Pim-1 in lanes 3
and 6), but the non-speci¢c IgG did not (Fig. 2A, F-Pim-1
in lanes 2 and 5). HA-TFAF2, on the other hand, was de-
tected in the immunoprecipitate from cells transfected with
both FLAG-Pim-1-wt and FLAG-Pim-1-KM (Fig. 2A, HA-
TFAF2 in lanes 3 and 6), indicating that TFAF2 was associ-
ated with the wild-type and mutant form of Pim-1 in ectopic-
expressed 293T cells.
Since Pim-1 is a serine/threonine protein kinase, it is possi-
ble that TFAF2 is phosphorylated by Pim-1. To investigate
this possibility, GST, GST^TFAF2 and GST^Pim-1 were pu-
ri¢ed from the expressed E. coli, and then GST-free Pim-1 was
prepared after the digestion of GST^Pim-1 with PreScission
protease. Both GST^TFAF2 and Pim-1 were incubated with
[Q-32P]ATP, and the labeled proteins were separated on the gel
(Fig. 2B). Pim-1 was autophosphorylated irrespective of the
kinds of substrate proteins, and GST^TFAF2, but not GST,
was phosphorylated with Pim-1 (Fig. 2B, lanes 2 and 1, re-
spectively). A kinase-negative mutant of Pim-1 did not phos-
phorylate GST^TFAF2 (data not shown).
3.2. Translocation of TFAF2/SNX6 from the cytoplasm to
nucleus by Pim-1 in cells
Previous studies have shown that SNX6 is localized in the
cytoplasm to target proteins to the Golgi network in the cells
[23], and we have also found that TFAF2 is associated with
TRAF4 in the Golgi body (data not shown). To determine the
cellular localization of TFAF2/SNX6 and Pim-1, expression
vectors for FLAG-Pim-1-wt or FLAG-Pim-1-KM Pim-1 and
HA-TFAF2 were transfected alone or together into human
HeLa cells. Two days after transfection, the cells were stained
with anti-FLAG and anti-HA antibodies, and the proteins
were detected by FITC- and rhodamine-conjugated second
antibodies, respectively, and then visualized under a confocal
laser microscope (Fig. 3). The anti-HA antibody was ¢rst
con¢rmed not to stain FLAG-Pim-1 in transfected cells
(data not shown). Both wild-type and kinase-negative Pim-1
(green) were localized in nucleus, while HA-TFAF2 (red) was
localized in the cytoplasm (Fig. 3A). When both FLAG-Pim-1
and HA-TFAF2 were cotransfected into HeLa cells, 50^70%
of HA-TFAF2 was translocated to the nucleus and 25^30% of
it was present both in the cytoplasm and nuclei, irrespective of
the presence or absence of phosphorylation activity of Pim-1.
Pim-1 and TFAF2 were colocalized in nuclei as shown by the
yellow color (Fig. 3B, merge), and distributions of HA-
TFAF2 in cells transfected with or without FLAG-Pim-1
were calculated (Fig. 3C). EGFP (promoter)-tagged TFAF2
was also used and found to be in the same localization in cells
as that of HA-TFAF2 (data not shown). These results indi-
cate that Pim-1 determines the location of TFAF2/SNX6 in
cells. In order to con¢rm the above results, the e¡ects of the
Pim-1-deletion mutants on the localization of TFAF2/SNX6
Fig. 2. Association of Pim-1 with TFAF2 in human 293T cells and phosphorylation of TFAF2 by Pim-1. A: Pim-1-wt, Pim-1-KM and
TFAF2 were tagged with either FLAG or HA, and their expression vectors were co-introduced into human 293T cells. Two days after transfec-
tion, cell extracts were prepared, and the proteins in the extracts were ¢rst immunoprecipitated (IP) with an anti-FLAG antibody or non-specif-
ic IgG. The proteins in the precipitates were separated in a 12% polyacrylamide gel and blotted with the anti-FLAG or an anti-HA antibody
(12CA5). 1/50 volumes of the extract used for the binding reaction were applied to the same gel (input, lanes 1 and 4). B: GST by itself and
GST fusion proteins of TFAF2 were expressed in E. coli, puri¢ed, and incubated in the presence of [Q-32P]ATP and GST-free Pim-1. Labeled
proteins bound to the resin were then separated in a 12% polyacrylamide gel and autoradiographed.
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in cells were further examined. First, Pim-1-deletion mutants
alone were transfected into HeLa cells and stained with the
anti-FLAG antibody (Fig. 4A). Nuclei was stained with
DAPI. Pim-1-v1, containing amino acids 1^230, was found
to be located as a speckle or a dot in nuclei, whereas Pim-1-
wt was located uniformly in the nucleus with some staining in
the cytoplasm. Pim-1v2, spanning amino acids 1^97, was
mainly located in the nucleus with much more cytoplasm lo-
calization than that of Pim-1-wt. Nuclear staining of Pim-1v2
was likely to be emphasized due to the sickness of the nucleus.
Only nuclei of Pim-1v3, which lacks amino acids 1^97, and
Pim-1v5 containing amino acids 98^230, were stained. Since
the sizes of FLAG-tagged-deletion mutants of Pim-1 were
small enough to di¡use to nucleus, EGFP-tagged Pim-1-dele-
tion mutants were transfected into HeLa cells and their dis-
tribution in cells were tested. Since molecular weight of EGFP
is 27 kDa, all the Pim-1-deletion mutants are not able to
di¡use to the nucleus by themselves. Pim-1v2-wt and Pim-
1v3-wt were found to have the same localization as that of
the FLAG-tagged versions and the nuclear localization of
Pim-1v3 was con¢rmed. Contrary to the location of the
FLAG-tagged version, Pim-1v1 and Pim-1v5 were located
as a speckle or a dot outside of nucleus, indicating that nu-
clear location of FLAG-Pim-1v1 and Pim-1v5 was due to the
di¡usion. These results also suggested that a nuclear localiza-
tion signal is present in amino acids 230^313 in Pim-1, and
this signal is necessary but not su⁄cient for nuclear location
of Pim-1, since some parts of Pim-1v2 are still located in the
nucleus. Furthermore, since the nucleotide sequences corre-
sponding to the typical nuclear localization signal so far an-
alyzed are not present in Pim-1, some proteins that bind to the
nuclear localization signal present in amino acids 230^313 or
to Pim-1v2 might catalyze the nuclear translocation of Pim-1.
The expression vectors for FLAG-Pim-1-deletion mutants, v1,
v2 and v3, were then cotransfected with HA-TFAF2 into
HeLa cells, and both proteins were stained (Fig. 4B). The
main parts of TFAF2 were colocalized with Pim-1-wt uni-
formly in nuclei. In the case of Pim-1v1 and Pim-1v2, lacking
nuclear localization signals, both proteins were colocalized as
a speckle outside of the nucleus, which is the reported local-
ization of TFAF2/TNX6 [22,23]. In the case of Pim-1v3 that
contains the nuclear localization signal, on the other hand, the
majority of TFAF2 were translocated to the nuclei and some
parts of TFAF2 remained in the cytoplasm. These results
suggest that TFAF2/SNX6 is translocated from the cytoplasm
to nuclei by the nuclear localization signal present in Pim-1.
The sorting nexins have been found to be a family of cyto-
plasmic and membrane-associated proteins that are thought
to function in the intracellular tra⁄cking of plasma-mem-
brane receptors. All the sorting nexin-family proteins contain
a PX domain, and more than 10 sorting nexin-family proteins
in mammals have been identi¢ed ([28], the references therein).
SNX6 was ¢rst identi¢ed as a protein interacting with Smad1
[22]. Recently, SNX6 has been found to bind more strongly
with the TGF-L receptors of serine/threonine kinase as well as
EGF, insulin or platelet-derived growth factor receptors of
tyrosine kinase and to be located in the cytoplasm and mem-
brane [23]. We ¢rst identi¢ed TFAF2 as a protein binding to
TRAF4, and TFAF2 was later found to be identical to
TNX6. Furthermore, TFAF2 and TRAF4 were found to be
colocalized in the Golgi body (data not shown). On the other
hand, Pim-1 is thought to function in cell-cycle progression,
induction or suppression of apoptosis, or transcription regu-
lation by phosphorylating proteins contributing to these pro-
cesses, and several nuclear proteins, including p100 [10],
Cdc25A [11], PAP-1 [13] and HP-1 [12], have been identi¢ed
as binding- and phosphorylation-target proteins. What is the
Fig. 3. Translocation of TFAF2 from cytoplasm to nucleus by Pim-
1. A: HeLa cells were transfected with expression vectors for
FLAG-Pim-1-wt, FLAG-Pim-1-KM and HA-TFAF2 by the calcium
phosphate precipitation technique. Two days after transfection, the
cells were ¢xed, reacted with an anti-FLAG monoclonal antibody
(M2, Sigma) and an anti-HA polyclonal antibody (Y-11, Santa
Cruz), and visualized with a £uorescein isothiocyanate-conjugated
anti-mouse IgG and a rhodamine-conjugated anti-rabbit IgG, re-
spectively. B: HeLa cells were cotransfected with expression vectors
for FLAG-Pim-1-wt, FLAG-Pim-1-KM and HA-TFAF2 and then
stained as described in (A). The two ¢gures have been merged
(merge). C: More than 200 cells cotransfected with FLAG-Pim-1-
wt, FLAG-Pim-1-KM and HA-TFAF2 were stained as described in
(A), and the number of cells which contain Pim-1 located in the cy-
toplasm, nuclei or cytoplasm+nuclei in each transfected cell was
counted.
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function of nuclei-targeted SNX6/TFAF2? From the sup-
ported function of cytoplasm- or membrane-located SNX pro-
teins, it is possible that Pim-1 is recruited to the regions in
nucleus, in which Pim-1 functions or is degraded, by SNX6/
TFAF2. These processes, di¡erent from those of the phos-
phorylation-target proteins of Pim-1, may not need the phos-
phorylation function of Pim-1. We are now examining these
possibilities.
Fig. 4. E¡ect of Pim-1 deletion mutants on the localization of TFAF2. A: FLAG-Pim-1-wt or four deletion mutants of Pim-1, v1, v2, v3, v5,
was transfected into HeLa cells and stained with an anti-FLAG antibody, followed by a £uorescein isothiocyanate-conjugated anti-mouse IgG
as described in Fig. 3A. EGFP-tagged Pim-1-wt or three deletion mutants of Pim-1, v1^v3, was also transfected into HeLa cells and the nuclei
were stained with DAPI. These two ¢gures have been merged (merge). B: HeLa cells were cotransfected with expression vectors for FLAG-
Pim-1-wt, FLAG-Pim-1 deletion mutants and HA-TFAF2, and then stained as described in Fig. 3A. The two ¢gures have been merged
(merge).
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